Clinical Trial Update: The Impact of Systemic Light Chain Amyloidosis on Eyes

View source ↗

Summary

A clinical trial is recruiting to evaluate the impact of systemic light-chain (AL) amyloidosis on the eyes and associated ocular complications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Light-chain Amyloidosis

Snippet

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University | Conditions: Systemic Light Chain Amyloidosis, Ocular Complications | Status: RECRUITING